Biotricity (BTCY)
(Delayed Data from NSDQ)
$0.82 USD
-0.01 (-1.56%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $0.80 -0.02 (-2.79%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.82 USD
-0.01 (-1.56%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $0.80 -0.02 (-2.79%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum A VGM
Zacks News
Biotricity (BTCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Biotricity (BTCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Biotricity Inc. (BTCY)
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Biotricity Inc. (BTCY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Biotricity Inc. (BTCY) have performed compared to their sector so far this year.
Biotricity Inc. (BTCY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Biotricity Inc. (BTCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Biotricity Inc. (BTCY) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Biotricity Inc. (BTCY) delivered earnings and revenue surprises of 17.07% and 0.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Foundation Medicine (FMI) Jumps: Stock Adds 10.6% in Session
by Zacks Equity Research
Foundation Medicine, Inc. (FMI) moved big last session, as its shares rose over 10% on the day.